MD4626C1 - Derivaţi de tamoxifen pentru tratamentul afecţiunilor neoplazice, în special cu nivel înalt de proteină HER2 - Google Patents

Derivaţi de tamoxifen pentru tratamentul afecţiunilor neoplazice, în special cu nivel înalt de proteină HER2

Info

Publication number
MD4626C1
MD4626C1 MD20150117A MD20150117A MD4626C1 MD 4626 C1 MD4626 C1 MD 4626C1 MD 20150117 A MD20150117 A MD 20150117A MD 20150117 A MD20150117 A MD 20150117A MD 4626 C1 MD4626 C1 MD 4626C1
Authority
MD
Moldova
Prior art keywords
tamoxifen
treatment
neoplastic diseases
her2 protein
general formula
Prior art date
Application number
MD20150117A
Other languages
English (en)
Russian (ru)
Other versions
MD4626B1 (ro
MD20150117A2 (ro
Inventor
Jan Štursa
Lukáš Werner
Jiří Neužil
Original Assignee
Smart Brain Sro
Biotechnologicky Ustav Av Cr V V I
Neuzil Jiri
Kkcg Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=50677895&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MD4626(C1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from CZ2013-308A external-priority patent/CZ2013308A3/cs
Priority claimed from CZ2014-66A external-priority patent/CZ305571B6/cs
Application filed by Smart Brain Sro, Biotechnologicky Ustav Av Cr V V I, Neuzil Jiri, Kkcg Ag filed Critical Smart Brain Sro
Publication of MD20150117A2 publication Critical patent/MD20150117A2/ro
Publication of MD4626B1 publication Critical patent/MD4626B1/ro
Publication of MD4626C1 publication Critical patent/MD4626C1/ro

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/54—Quaternary phosphonium compounds
    • C07F9/5456—Arylalkanephosphonium compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/54—Quaternary phosphonium compounds
    • C07F9/5442—Aromatic phosphonium compounds (P-C aromatic linkage)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/54—Quaternary phosphonium compounds
    • C07F9/5449—Polyphosphonium compounds
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B23/00—Methine or polymethine dyes, e.g. cyanine dyes
    • C09B23/0008—Methine or polymethine dyes, e.g. cyanine dyes substituted on the polymethine chain
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B23/00—Methine or polymethine dyes, e.g. cyanine dyes
    • C09B23/0008—Methine or polymethine dyes, e.g. cyanine dyes substituted on the polymethine chain
    • C09B23/0025—Methine or polymethine dyes, e.g. cyanine dyes substituted on the polymethine chain the substituent being bound through an oxygen atom
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B23/00—Methine or polymethine dyes, e.g. cyanine dyes
    • C09B23/14—Styryl dyes
    • C09B23/141—Bis styryl dyes containing two radicals C6H5-CH=CH-
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B69/00—Dyes not provided for by a single group of this subclass
    • C09B69/001—Dyes containing an onium group attached to the dye skeleton via a bridge
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B69/00—Dyes not provided for by a single group of this subclass
    • C09B69/008—Dyes containing a substituent, which contains a silicium atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Epidemiology (AREA)

Abstract

Prezenta invenţie se referă la noi izomeri E/Z direcţionaţi mitocondrial ai derivaţilor de trifenilfosfoniu alifatic ai tamoxifenului, în care lanţul alifatic este alchil sau alchenil, şi la sărurile aminice terţiare corespunzătoare ale acestora, şi/sau la amestecurile acestora (MitoTax). Derivaţii de alchil trifenilfosfoniu ai tamoxifenului au formula generală (I):I,în care n = 8…12 şi Z este selectat dintr-o grupă de săruri organice sau anorganice.Derivaţii de alchenil trifenilfosfoniu ai tamoxifenului au formula generală IA:IA,în care n = 6…10 şi Z are semnificaţiile definite mai sus.Aceşti compuşi sunt aplicabili pentru tratamentul bolilor neoplazice, în special al celor cu niveluri înalte de proteină HER2. Medicamentul pentru tratamentul bolilor neoplazice, conform prezentei invenţii, conţine cel puţin un izomer E/Z al derivaţilor de trifenilfosfoniu alifatic ai tamoxifenului cu formula generală (I) şi/sau IA, sau sărurile lor corespunzătoare ale aminelor terţiare.
MD20150117A 2013-04-24 2014-04-07 Derivaţi de tamoxifen pentru tratamentul afecţiunilor neoplazice, în special cu nivel înalt de proteină HER2 MD4626C1 (ro)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CZ2013-308A CZ2013308A3 (cs) 2013-04-24 2013-04-24 Deriváty tamoxifenu účinné proti nádorům, zejména s vyšší hladinou proteinu HER2
CZ2014-66A CZ305571B6 (cs) 2014-01-29 2014-01-29 Deriváty tamoxifenu k léčbě neoplastických chorob, zejména s vyšší hladinou proteinu HER2
PCT/CZ2014/000035 WO2014173374A1 (en) 2013-04-24 2014-04-07 Tamoxifen derivatives for treatment of neoplastic diseases, especially with high her2 protein level

Publications (3)

Publication Number Publication Date
MD20150117A2 MD20150117A2 (ro) 2016-08-31
MD4626B1 MD4626B1 (ro) 2019-04-30
MD4626C1 true MD4626C1 (ro) 2019-11-30

Family

ID=50677895

Family Applications (1)

Application Number Title Priority Date Filing Date
MD20150117A MD4626C1 (ro) 2013-04-24 2014-04-07 Derivaţi de tamoxifen pentru tratamentul afecţiunilor neoplazice, în special cu nivel înalt de proteină HER2

Country Status (22)

Country Link
US (1) US9896466B2 (ro)
EP (1) EP2989110B1 (ro)
JP (1) JP6375091B2 (ro)
KR (1) KR101764991B1 (ro)
CN (1) CN105452265B (ro)
AU (1) AU2014256546B2 (ro)
CA (1) CA2909994C (ro)
CY (1) CY1120821T1 (ro)
DK (1) DK2989110T3 (ro)
EA (1) EA029881B1 (ro)
ES (1) ES2699099T3 (ro)
GE (1) GEP20186868B (ro)
HK (1) HK1216317A1 (ro)
HR (1) HRP20181872T1 (ro)
HU (1) HUE042239T2 (ro)
MD (1) MD4626C1 (ro)
NZ (1) NZ713589A (ro)
PL (1) PL2989110T3 (ro)
PT (1) PT2989110T (ro)
SI (1) SI2989110T1 (ro)
UA (1) UA116469C2 (ro)
WO (1) WO2014173374A1 (ro)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2018000295A (es) * 2015-07-03 2018-03-08 Bayer Cropscience Ag Derivados de n-(tetrazol-5-il)- y n-(triazol-5-il)arilcarboxamida con accion herbicida.
PL3317272T3 (pl) * 2015-07-03 2020-01-31 Bayer Cropscience Aktiengesellschaft Chwastobójczo skuteczne pochodne N-(1,3,4-oksadiazol-2-ilo)arylokarboksyamidowe
JP2019525955A (ja) * 2016-07-12 2019-09-12 アキュター バイオテクノロジー インコーポレイテッド 新規化合物およびその使用
JP7100019B2 (ja) 2016-08-19 2022-07-12 ザ ユナイテッド ステイツ オブ アメリカ， アズ リプレゼンテッド バイ ザ セクレタリー， デパートメント オブ ヘルス アンド ヒューマン サービシーズ 選択的エストロゲン受容体モジュレーター（ｓｅｒｍ）は、光受容体の変性に対する保護を付与する
EP3330274A1 (en) * 2016-12-01 2018-06-06 Springtide Ventures s.r.o. Compounds for treatment of senescence-related disorders
US11197872B2 (en) 2017-04-21 2021-12-14 Lunella Biotech, Inc. Vitamin C and doxycycline: a synthetic lethal combination therapy for eradicating cancer stem cells (CSCs)
CA3060509A1 (en) 2017-04-21 2018-10-25 Federica Sotgia Targeting hypoxic cancer stem cells (cscs) with doxycycline: implications for improving anti-angiogenic therapy
CR20190524A (es) 2017-05-19 2020-01-10 Lunella Biotech Inc Antimitoscinas: inhibidores específicos de la biogénesis mitocondrial para erradicar células madre cancerosas
CR20200218A (es) 2017-10-24 2020-12-23 Lunella Biotech Inc Mitoflavoscinas: la fijaciòn como objetivo de enzimas que contienen flavina elimina cèlulas madre cancerosas (cscs) al inhibir la respiraciòn mitocondrial
CA3083023A1 (en) 2017-11-24 2019-05-31 Lunella Biotech, Inc. Triphenylphosphonium-derivative compounds for eradicating cancer stem cells
US11497759B2 (en) 2017-12-01 2022-11-15 Lunella Biotech, Inc. Repurposcins: targeted inhibitors of mitochondrial biogenesis for eradicating cancer stem cells
WO2019113210A1 (en) 2017-12-05 2019-06-13 Anthos Partners, Lp Phosphonium-based ionic drug conjugates
EP3728300A4 (en) 2017-12-20 2021-08-11 Lunella Biotech, Inc. TARGETING MITOCHONDRIAL FISSION VIA MDIVI-1 DERIVATIVES
US20220211728A1 (en) * 2019-04-16 2022-07-07 Lunella Biotech, Inc. Alkyl-tpp compounds for mitochondria targeting and anti-cancer treatments
EP3753944A1 (en) 2019-06-17 2020-12-23 Institute Of Biotechnology Cas, V.V.I. 3,5-bis(phenyl)-1h-heteroaryl derivatives as medicaments

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1289570C (en) * 1986-06-16 1991-09-24 Tetsuji Asao 1,1,2-triaryl-1-alkene derivatives
CA2092996A1 (en) * 1990-10-01 1992-04-02 David Yang High affinity tamoxifen derivatives and uses thereof
JP3635708B2 (ja) * 1995-03-06 2005-04-06 出光興産株式会社 有機エレクトロルミネッセンス素子
TWI309571B (en) * 2002-12-31 2009-05-11 Ind Tech Res Inst Delivery carrier for targeting cells haring over-expressed estrogen
NZ546070A (en) * 2003-08-22 2010-01-29 Antipodean Pharmaceuticals Inc Mitoquinone derivatives used as mitochondrially targeted antioxidants
RU2007105138A (ru) * 2004-07-13 2008-08-20 Оридис Биомед Форшунгс-Унд Энтвиклунгс Гмбх (At) Применение митохондриально направленного антиоксиданта при лечении болезней печени и эпителиальных раковых опухолей
JP5616798B2 (ja) * 2008-03-14 2014-10-29 スティーブン・ジョン・ラルフＳｔｅｐｈｅｎ Ｊｏｈｎ ＲＡＬＰＨ ミトコンドリア由来の抗ガン化合物
MX2011010956A (es) * 2009-04-17 2012-01-27 Colby Pharmaceutical Company Composiciones farmaceuticamente activas que comprenden moduladores de estres oxidativo (osm por sus siglas en inglés), nuevas entidades quimicas, composiciones y usos.
WO2011129837A1 (en) * 2010-04-16 2011-10-20 Olema Pharmaceuticals, Inc. Use of a 4-hydroxytoremifene prodrug for treatment of breast cancer

Also Published As

Publication number Publication date
AU2014256546B2 (en) 2017-03-30
US20160075726A1 (en) 2016-03-17
ES2699099T3 (es) 2019-02-07
KR101764991B1 (ko) 2017-08-10
HUE042239T2 (hu) 2019-06-28
JP6375091B2 (ja) 2018-08-15
CN105452265A (zh) 2016-03-30
EA029881B1 (ru) 2018-05-31
CY1120821T1 (el) 2019-12-11
JP2016522179A (ja) 2016-07-28
MD4626B1 (ro) 2019-04-30
NZ713589A (en) 2017-12-22
DK2989110T3 (en) 2018-12-03
PT2989110T (pt) 2018-11-15
GEP20186868B (en) 2018-06-25
HK1216317A1 (zh) 2016-11-04
WO2014173374A1 (en) 2014-10-30
MD20150117A2 (ro) 2016-08-31
UA116469C2 (uk) 2018-03-26
HRP20181872T1 (hr) 2019-02-08
US9896466B2 (en) 2018-02-20
EP2989110B1 (en) 2018-08-08
AU2014256546A1 (en) 2015-11-12
CN105452265B (zh) 2017-05-10
CA2909994A1 (en) 2014-10-30
SI2989110T1 (sl) 2019-01-31
CA2909994C (en) 2018-06-26
KR20150144756A (ko) 2015-12-28
EP2989110A1 (en) 2016-03-02
PL2989110T3 (pl) 2019-03-29
EA201591918A1 (ru) 2016-02-29

Similar Documents

Publication Publication Date Title
MD4626B1 (ro) Derivaţi de tamoxifen pentru tratamentul afecţiunilor neoplazice, în special cu nivel înalt de proteină HER2
ECSP24026455A (es) Compuestos de pirrolotriazina como inhibidores de tam
CY1120635T1 (el) Βενζαμιδια αμινοετεροαρυλιου ως αναστολεις κινασης
ECSP18094790A (es) Piridinas sustituidas con heteroarilo y métodos de uso referencia cruzada a solicitudes relacionadas
EA201890308A1 (ru) Замещенные азасоединения как ингибиторы irak-4
DOP2017000066A (es) Compuestos y composiciones como inhibidores de quinasa raf
BR112018007381A2 (pt) compostos úteis como imunomoduladores
NI201600165A (es) Inhibidores de desmetilasa 1 específica a lisina
CO2018000589A2 (es) Oxiesteroles y composiciones farmacéuticas que los contienen
GEP20207105B (en) 1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2yl carbamate derivatives as magl inhibitors
BR112015023753A2 (pt) composições, formulações e métodos para o tratamento de doenças oculares
DOP2017000278A (es) Piridinas sustituidas y método de uso
UY35737A (es) Pesticidas de azol bicíclico sustituido con heterociclos
CR20160478A (es) Composición de control de enfermedades de plantas y método para controlar enfermedades de plantas mediante su aplicación
DOP2017000107A (es) Diamino-quinoleina 2,4 sustituida como nuevos agentes anticancerigenos
UY36875A (es) Composiciones inhibidoras de bromodominios para el tratamiento de diversas enfermedades
BR112016024936A2 (pt) moduladores de gpr40 à base de pirrolidina para tratamento de doenças como diabetes
EA202090368A1 (ru) Соединения-ингибиторы рецептора лизофосфатидной кислоты 1 (lpar1)
CL2020001047A1 (es) Derivados de imidazol condensado sustituidos por grupos de hidroxia terciaria como inhibidores pi3k-gamma.
MX2018008671A (es) Composicion para incrementar la expresion de pgc-1alfa.
CL2018001631A1 (es) Compuestos de dihidroquinolinsulfonamida de alquilo
MX2020004842A (es) Compuestos heterociclicos antiinfecciosos y sus usos.
DOP2016000211A (es) Pirazinas moduladoras de gpr6
CY1118552T1 (el) Νεα παραγωγα πυριμιδινης ως αναστολεις φωσφοδιεστερασης 10 (pde-10)
CO2018005698A2 (es) Composición para control de enfermedades de plantas, y método de control de enfermedades de plantas

Legal Events

Date Code Title Description
FG4A Patent for invention issued